,i  #aafth ,,congress  #b;d ,session    
,h4 ,r4 #hehh  ,,in ,,the ,,house ,,of  
,,representatives  ,october #ac1        
#bjbj,mr4 ,hudson 7for himself and ,ms4 
,blunt ,rochester7 introduced the       
following bill2 which was referred to   
the ,committee on ,energy and ,commerce1
 and in addition to the ,committee on   
,foreign ,affairs1 for a period to be   
subsequently determined by the ,speaker1
 in each case for consideration of such 
provisions as fall within the           
jurisdiction of the committee concerned 
,a ,,bill  ,to provide for a study on   
the current and historical production of
 drugs in the ,united ,states and in    
foreign countries1 and for other        
purposes4  #a4 ,short title ,this ,act  
may be cited as the ,improving the      
,american ,drug ,supply ,chain ,act of  
#bjbj4  #b4 ,study and reporting on     
domestic and foreign production  7a7 ,in
 general ,the ,secretary of ,health and 
,human ,services shall enter into an    
agreement with the ,national ,academies 

of ,sciences1 ,engineering1 and         
,medicine 7referred to in this section  
as the ,national ,academies7 under      
which1 not later than #bd months after  
the date of enactment of this ,act1 the 
,national ,academies will-- 7#a7 study  
the current and historical production of
 drugs and key ingredients thereof      
7including active pharmaceutical        
ingredients7 in the ,united ,states and 
in foreign countries2  7#b7 formulate   
recommendations for promoting increased 
production of drugs and key ingredients 
thereof 7including active pharmaceutical
 ingredients7 in the ,united ,states2   
and  7#c7 in a manner that does not     
compromise national security or disclose
 trade secrets or other confidential    
commercial information that is subject  
to section #eeb7;b77#d7 of title #e1    
,united ,states ,code1 or section #aije 
of title #ah1 ,united ,states ,code1    
submit a report to the ,congress on--   
7,a7 the findings and conclusions of the
 study under paragraph 7#a72 and  7,b7  

the recommendations under paragraph     
7#b74  7b7 ,study topics ,the study     
pursuant to subsection 7a77#a7 shall    
include-- 7#a7 evaluation of-- 7,a7 the 
extent to which production of drugs for 
use in the ,united ,states and key      
ingredients thereof 7including active   
pharmaceutical ingredients7 takes place 
in the ,united ,states2 and  7,b7 the   
extent to which such production takes   
place in foreign countries2  7#b7       
identification of the foreign countries 
in which such production takes place2   
7#c7 evaluation of historical changes in
 the countries in which such production 
takes place2  7#d7 determination of the 
reasons why such production takes place 
in foreign countries1 including why such
 production takes place in particular   
foreign countries1 including            
consideration of-- 7,a7 the reasons for 
historical migration of such production 
to foreign countries1 or from foreign   
countries to other foreign countries or 
the ,united ,states2  7,b7 economic     

factors1 including economic impediments 
to domestic production and incentives   
for foreign production2 and  7,c7       
regulatory1 intellectual property1      
international trade1 and other legal and
 policy factors2 and  7#e7 evaluation of
 the benefits of redundancies in the    
supply chain of drugs in the ,united    
,states in the event of a public health 
emergency4  7c7 ,recommendations ,the   
agreement under subsection 7a7 shall--  
7#a7 provide for inclusion in the       
recommendations under subsection 7a77#b7
 of measures 7which may include         
statutory1 regulatory1 and other policy 
changes7 that should be taken-- 7,a7 to 
encourage the domestic production of    
drugs for use in the ,united ,states and
 key ingredients thereof 7including     
active pharmaceutical ingredients72 or  
7,b7 to otherwise reduce the risks to   
the availability of drugs in the ,united
 ,states in the event of a public health
 emergency2 and  7#b7 require           
consideration1 in developing such       

recommendations1 of-- 7,a7 factors      
affecting the production of drugs1      
including-- 7i7 access to skilled labor2
  7ii7 the cost of raw materials1 the   
cost of energy1 and related costs2      
7iii7 taxes and other incentives2 and   
7iv7 the effects of regulations2 and    
7,b7 the costs and consequences of      
implementing1 or failing to implement1  
each such recommendation4  7d7 ,input   
,the agreement under subsection 7a7     
shall require-- 7#a7 consideration of   
input from the ,department of ,health   
and ,human ,services1 the ,department of
 ,commerce1 and1 as appropriate1 other  
,federal agencies2 and  7#b7            
consultation with relevant stakeholders1
 which-- 7,a7 may include conducting    
public meetings and other forms of      
engagement1 as appropriate2  7,b7 shall 
include consultation with experts in--  
7i7 the manufacturing of drugs2  7ii7   
pharmaceutical industry business and    
economics2  7iii7 drug purchasing1      
pricing1 and reimbursement2  7iv7       

regulatory and intellectual property    
issues affecting drug manufacturing2    
7v7 economics2  7vi7 international trade
 policy2 and  7vii7 emergency planning2 
and  7,c7 may include consultation with 
other entities with experience in drug  
manufacturing and pricing1 as           
appropriate4  7e7 ,definitions ,in this 
section1 the term drug has the meaning  
given such term in section #bja of the  
,federal ,food1 ,drug1 and ,cosmetic    
,act 7#ba ,u4,s4,c4 #cba74